These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38751658)

  • 1. Stem Cell Therapy, the Market, the Opportunities and the Threat.
    Bahari M; Mokhtari H; Yeganeh F
    Int J Mol Cell Med; 2023; 12(3):310-319. PubMed ID: 38751658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Market access pathways for cell therapies in France.
    Rémuzat C; Toumi M; Jørgensen J; Kefalas P
    J Mark Access Health Policy; 2015; 3():. PubMed ID: 27123176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies.
    Ratcliffe E; Glen KE; Naing MW; Williams DJ
    Br Med Bull; 2013; 108():73-94. PubMed ID: 24200742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The market trend analysis and prospects of scaffolds for stem cells.
    Lee S; Kwon T; Chung EK; Lee JW
    Biomater Res; 2014; 18():11. PubMed ID: 26331062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell industry update: 2012 to 2016 reveals accelerated investment, but market capitalization and earnings lag.
    Ng M; Song S; Piuzzi NS; Ng K; Gwam C; Mont MA; Muschler GF
    Cytotherapy; 2017 Oct; 19(10):1131-1139. PubMed ID: 28807603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model.
    Viswanathan S; Rao M; Keating A; Srivastava A
    Stem Cells Transl Med; 2013 Aug; 2(8):607-13. PubMed ID: 23836804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: international regulatory considerations on development pathways for cell therapies.
    Feigal EG; Tsokas K; Viswanathan S; Zhang J; Priest C; Pearce J; Mount N
    Stem Cells Transl Med; 2014 Aug; 3(8):879-87. PubMed ID: 25038248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.
    Chan S
    Regen Med; 2017 Oct; 12(7):839-851. PubMed ID: 29119870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments.
    Lomax GP; Torres A; Millan MT
    Stem Cells Transl Med; 2020 May; 9(5):547-553. PubMed ID: 32040254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access.
    Driscoll D; Farnia S; Kefalas P; Maziarz RT
    Stem Cells Transl Med; 2017 Aug; 6(8):1723-1729. PubMed ID: 28749065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues.
    Park SJ; Kim YY; Han JY; Kim SW; Kim H; Ku SY
    Tissue Eng Regen Med; 2024 Apr; 21(3):379-394. PubMed ID: 38502279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cell Therapy Catapult: growing a U.K. cell therapy industry generating health and wealth.
    Thompson K; Foster EP
    Stem Cells Dev; 2013 Dec; 22 Suppl 1():35-9. PubMed ID: 24304073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the Role of Biopolymer Aerogel Scaffolds in Tissue Engineering and Regenerative Medicine.
    Yahya EB; Amirul AA; H P S AK; Olaiya NG; Iqbal MO; Jummaat F; A K AS; Adnan AS
    Polymers (Basel); 2021 May; 13(10):. PubMed ID: 34067569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating regenerative medicine: the Japanese experiment in ethics and regulation.
    Lysaght T
    Regen Med; 2017 Sep; 12(6):657-668. PubMed ID: 28976822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of stem cell-based therapies: an overview.
    Aly RM
    Stem Cell Investig; 2020; 7():8. PubMed ID: 32695801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
    Azuma K; Yamanaka S
    Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on formation of medical cannabis market in Ukraine based on holistic approach.
    Aliekperova N; Kosyachenko К; Kaniura O
    J Cannabis Res; 2020 Oct; 2(1):33. PubMed ID: 33526139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.